CGRP-antibodies
Showing 1 - 25 of 4,079
Headache, Migraine Trial in Chicago, Naperville (Ubrogepant 50 MG [Ubrelvy], Ubrogepant 100 MG [Ubrelvy])
Not yet recruiting
- Headache, Migraine
- Ubrogepant 50 MG [Ubrelvy]
- Ubrogepant 100 MG [Ubrelvy]
-
Chicago, Illinois
- +1 more
Aug 14, 2022
Chronic Migraine Trial (KOS (Intranasal kinetic oscillation stimulation))
Not yet recruiting
- Chronic Migraine
- KOS (Intranasal kinetic oscillation stimulation)
- (no location specified)
Apr 14, 2022
BIOmarkers of MIGraine:Proof of Concept Study Based on
Recruiting
- Migraine
-
Hamburg, Germany
- +2 more
Apr 27, 2021
Anti-CGRP Monoclonal Antibody Response After Switching (AMARAS)
Recruiting
- Migraine
- Head Pain
-
Valladolid, SpainHospital Clínico Universitario de Valladolid
Mar 23, 2023
Caused by Anti-CGRP mAbs in Migraine Patients Treated With
Recruiting
- Migraine Disorders
- Diagnostic radiology
-
Lugano, Ticino, SwitzerlandChiara ZECCA
Sep 6, 2023
Migraine Disorders, Chronic Migraine, Episodic Migraine Trial in Pavia (Monoclonal antibody targeting the CGRP pathway (ligand
Recruiting
- Migraine Disorders
- +2 more
- Monoclonal antibody targeting the CGRP pathway (ligand or receptor) (mAbs)
-
Pavia, ItalyHeadache Science & Neurorehabilitation Center
Nov 23, 2023
CGRP Inhibition, Autonomic Function, and Migraine
Recruiting
- Episodic Migraine
- Chronic Migraine
- Erenumab
- +2 more
-
Vienna, AustriaMedical University of Vienna
Apr 8, 2022
New Persistent Daily Headache Trial (CGRP antibody)
Not yet recruiting
- New Persistent Daily Headache
- CGRP antibody
- (no location specified)
Aug 29, 2023
MIDAS Reduction at 3 Months for Erenumab Treatment
Completed
- Migraine
- Erenumab 70/140 mg s.c.
-
Pavia, ItalyHeadache Science & Neurorehabilitation Center
Jun 28, 2022
Monoclonal Antibody Duration of REsponse in MIgraine After
Recruiting
- Migraine
- Headache, Migraine
- Headache calendar completion
-
Valladolid, SpainHospital Clínico Universitario de Valladolid
Jul 15, 2022
Migraine Trial in Leuven (UB-313, Placebo)
Recruiting
- Migraine
- UB-313
- Placebo
-
Leuven, BelgiumKatholieke Universiteit Leuven
Jul 25, 2022
Psychological and Biological Markers of Refractory Migraine
Not yet recruiting
- Migraine
-
Pavia, ItalyHeadache Science Center
Sep 13, 2021
Acute Treatment of Migraine With Rimegepant 75 mg
Not yet recruiting
- Migraine Disorders
- Rimegepant 75 milligrams
-
Latina, Italy / Latina, ItalySapienza University of Rome Polo Pontino - ICOT
May 24, 2023
New Daily Persistent Headache Biomarkers Study
Terminated
- New Daily Persistent Headache
- New Daily Persistent Headache (NDPH)
-
Bronx, New YorkMontefiore Headache Center
Feb 15, 2022
Migraine, Episodic Migraine, Headache Trial in New York (Click Digital Therapeutic)
Recruiting
- Migraine
- +3 more
- Click Digital Therapeutic
-
New York, New YorkClick Therapeutics
Aug 15, 2023
Migraine Trial in L'Aquila (Blood sampling for microRNA testing)
Recruiting
- Migraine
- Blood sampling for microRNA testing
-
L'Aquila, ItalyUniversity of L'Aquila
Jul 1, 2021
Chronic Migraine Trial in Brookline (Emgality 120 MG in 1 ML Prefilled Syringe)
Recruiting
- Chronic Migraine
- Emgality 120 MG in 1 ML Prefilled Syringe
-
Brookline, MassachusettsPain Clinic at Beth Israel Deaconess Medical Center
Mar 16, 2022
Diabetic Polyneuropathy Trial in Rochester, Aarhus, Copenhagen (Eptinezumab, Placebo)
Not yet recruiting
- Diabetic Polyneuropathy
- Eptinezumab
- Placebo
-
Rochester, Minnesota
- +2 more
Jun 30, 2023
Migraine Trial in Talavera De La Reina (Transcranial direct current stimulation (tDCS), anti-CGRP-mAbs)
Completed
- Migraine
- Transcranial direct current stimulation (tDCS)
- anti-CGRP-mAbs
-
Talavera De La Reina, Toledo, SpainClinica de Intervencion en Neurociencias
Oct 15, 2023